ARCHIVES

Phase III Nexavar Trial Fails Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

Letter to the Editor

March 21, 2003

Working Group: Restructure NCI, Improve Review Process, Encourage Independence

July 14, 1995

National Organ Site Programs Successful, But Reappraisal Will Continue: Upton

June 23, 1978

Decision Delayed On Breast Cancer Study Until After Consensus Meeting

July 5, 1985

FDA, ASCO Meet to Review Drug Approval Endpoints

April 25, 2003

Decade-Long Cover-up?

January 6, 1995